A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
3/13/2026
BreakingCataractIOLRegulationSurgical
J&J Vision Gains US FDA Approval for Tecnis PureSee EDOF IOL
Johnson & Johnson Vision announced March 12 that it had gained US FDA approval for the Tecnis PureSee, an extended depth of focus (EDOF) intraocular lens (IOL) for use in cataract surgery. The Jack...
3/13/2026
BreakingDry EyeGlaucomaRefractiveRevenueSurgical
2025 Ophthalmic Revenue Roundup for STAAR Surgical and Sight Sciences
STAAR Surgical reported March 3 that its net sales in 2025 were $239.4 million, a 23.7 percent decline from $313.9 million in 2024. Q4-2025 net sales were $57.8 million, an 18.1 percent increase ov...
3/13/2026
BreakingPharmaRegulationRetina
US FDA Rejects Chiesi’s Idebenone for LHON, Asks for More Clinical Data
Chiesi reported March 5 that the US FDA had issued a complete response letter rejecting the company’s new drug application (NDA) for oral idebenone to treat Leber hereditary optic neuropathy (LHON)...
3/13/2026
BreakingEuropePharmaPresbyopiaRegulation
Lenz Submits Marketing Application for Vizz Presbyopia Drop in Europe
Lenz Therapeutics announced March 10 that it had submitted a marketing authorization application to the European Medicines Agency for Vizz, an eye drop targeting presbyopia. Vizz (aceclidine ophtha...
3/13/2026
BreakingCataractFundingIndiaSurgical
Aravind Eye Surgeons Named as 2026 Chang-Crandall Humanitarian Award Recipients
The ASCRS Foundation Board announced Feb. 5 that it had selected Aravind Haripriya, MD, and Rengaraj Venkatesh, MD, as the recipients of its 2026 Chang-Crandall Humanitarian Award. The honor was es...
3/13/2026
BreakingCataractIOLIndustrySingle-UseSurgical
Rayner Expands US Headquarters in Memphis Amid Milestone Successes
Rayner reported March 9 that it had opened a new 10 thousand-square-foot facility in Memphis, Tennessee, which will serve as its expanded US headquarters. The UK-based company said the move signifi...
3/13/2026
BreakingFundingGlaucomaStudy
Glaucoma Research Foundation Awards Record $3.06 Million in Annual Research Grants
The Glaucoma Research Foundation announced March 9 that it would distribute a record total of $3.06 million in annual research grants to support innovative research in glaucoma and neurodegeneratio...
3/13/2026
BreakingCataractDigitalIOLMicroscopesSurgical
Cassini Gains MDR Approval for Surgical Guidance System in the EU
Cassini Technologies, of the Netherlands, announced March 5 that its intraoperative guidance system for ophthalmic surgery had gained EU marketing authorization under the Medical Device Regulation ...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.